_id
690db11dccc777a4e85d0bcf
Ticker
ARTV
Name
Artiva Biotherapeutics, Inc. Common Stock
Exchange
NASDAQ
Address
5505 Morehouse Drive, San Diego, CA, United States, 92121
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.artivabio.com
Description
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.
Last Close
4.32
Volume
76016
Current Price
4.615
Change
0.195
Last Updated
2026-01-20T15:41:50.353Z
Image
data:image/webp;base64,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
Ipo Date
2024-07-19T00:00:00.000Z
Market Cap
82803336
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.6667
Target Price
17
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
662000
Gross Profit
-662000
Operating Expenses
22235000
Operating Income
-22897000
Interest Expense
-
Pretax Income
-21528000
Net Income
-21528000
Eps
-0.8793499084745754
Dividends Per Share
-
Shares Outstanding
24425762
Income Tax Expense
-
EBITDA
-20866000
Operating Margin
-
Total Other Income Expense Net
1369000
Cash
25508000
Short Term Investments
97460000
Receivables
879000
Inventories
-
Total Current Assets
129524000
Property Plant Equipment
18459000
Total Assets
148862000
Payables
848000
Short Term Debt
3172000
Long Term Debt
-
Total Liabilities
19638000
Equity
129223999
Bs_currency_symbol
USD
Depreciation
305000
Change In Working Capital
4897000
Cash From Operations
-19201000
Capital Expenditures
600000
Cash From Investing
16278000
Cash From Financing
-37000
Net Change In Cash
-2960000
Cf_currency_symbol
USD
PE
-
PB
0.8743201565059134
ROE
-16.65944419503687
ROA
-14.46171622039204
FCF
-19801000
Fcf Percent
-
Piotroski FScore
1
Health Score
42
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
4.5
Net Net Investing Score
5
Quality Investing Score
2.5
Value Investing Score
5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
662000
Quarters > 0 > income Statement > gross Profit
-662000
Quarters > 0 > income Statement > operating Expenses
22235000
Quarters > 0 > income Statement > operating Income
-22897000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-21528000
Quarters > 0 > income Statement > net Income
-21528000
Quarters > 0 > income Statement > eps
-0.8793499084745754
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
24481722
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-20866000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
1369000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
25508000
Quarters > 0 > balance Sheet > short Term Investments
97460000
Quarters > 0 > balance Sheet > receivables
879000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
129524000
Quarters > 0 > balance Sheet > property Plant Equipment
18459000
Quarters > 0 > balance Sheet > total Assets
148862000
Quarters > 0 > balance Sheet > payables
848000
Quarters > 0 > balance Sheet > short Term Debt
3172000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
19638000
Quarters > 0 > balance Sheet > equity
129223999
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-21528000
Quarters > 0 > cash Flow > depreciation
305000
Quarters > 0 > cash Flow > change In Working Capital
4897000
Quarters > 0 > cash Flow > cash From Operations
-19201000
Quarters > 0 > cash Flow > capital Expenditures
600000
Quarters > 0 > cash Flow > cash From Investing
16278000
Quarters > 0 > cash Flow > cash From Financing
-37000
Quarters > 0 > cash Flow > net Change In Cash
-2960000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.8793499084745754
Quarters > 0 > ratios > PB
0.8743201565059134
Quarters > 0 > ratios > ROE
-16.65944419503687
Quarters > 0 > ratios > ROA
-14.46171622039204
Quarters > 0 > ratios > FCF
-19801000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
22810000
Quarters > 1 > income Statement > operating Income
-22810000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-21254000
Quarters > 1 > income Statement > net Income
-21254000
Quarters > 1 > income Statement > eps
-0.8718222368651678
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
24378823
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-22169000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
1556000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
28468000
Quarters > 1 > balance Sheet > short Term Investments
113897000
Quarters > 1 > balance Sheet > receivables
30000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
149066000
Quarters > 1 > balance Sheet > property Plant Equipment
19826000
Quarters > 1 > balance Sheet > total Assets
169391000
Quarters > 1 > balance Sheet > payables
1215000
Quarters > 1 > balance Sheet > short Term Debt
3642000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
20350000
Quarters > 1 > balance Sheet > equity
149041000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-21254000
Quarters > 1 > cash Flow > depreciation
641000
Quarters > 1 > cash Flow > change In Working Capital
-3410000
Quarters > 1 > cash Flow > cash From Operations
-22983000
Quarters > 1 > cash Flow > capital Expenditures
1055000
Quarters > 1 > cash Flow > cash From Investing
21122000
Quarters > 1 > cash Flow > cash From Financing
-72000
Quarters > 1 > cash Flow > net Change In Cash
-1933000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.8718222368651678
Quarters > 1 > ratios > PB
0.7548813289296235
Quarters > 1 > ratios > ROE
-14.260505498486994
Quarters > 1 > ratios > ROA
-12.547301804700368
Quarters > 1 > ratios > FCF
-24038000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
41
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
22171000
Quarters > 2 > income Statement > operating Income
-22171000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-20311000
Quarters > 2 > income Statement > net Income
-20311000
Quarters > 2 > income Statement > eps
-0.834402200182746
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
24341978
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-21543000
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
1860000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
30401000
Quarters > 2 > balance Sheet > short Term Investments
135562000
Quarters > 2 > balance Sheet > receivables
234000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
170004000
Quarters > 2 > balance Sheet > property Plant Equipment
20785000
Quarters > 2 > balance Sheet > total Assets
191263000
Quarters > 2 > balance Sheet > payables
2036000
Quarters > 2 > balance Sheet > short Term Debt
3720000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
22480000
Quarters > 2 > balance Sheet > equity
168783000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-20311000
Quarters > 2 > cash Flow > depreciation
628000
Quarters > 2 > cash Flow > change In Working Capital
-1487000
Quarters > 2 > cash Flow > cash From Operations
-19841000
Quarters > 2 > cash Flow > capital Expenditures
511000
Quarters > 2 > cash Flow > cash From Investing
9971000
Quarters > 2 > cash Flow > cash From Financing
239000
Quarters > 2 > cash Flow > net Change In Cash
-9631000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.834402200182746
Quarters > 2 > ratios > PB
0.6655778631141762
Quarters > 2 > ratios > ROE
-12.033794872706375
Quarters > 2 > ratios > ROA
-10.61940887678223
Quarters > 2 > ratios > FCF
-20352000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
18267000
Quarters > 3 > income Statement > operating Income
-18267000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-9215000
Quarters > 3 > income Statement > net Income
-9215000
Quarters > 3 > income Statement > eps
-0.3782356438024212
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
24363119
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-17653000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
9052000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
40235000
Quarters > 3 > balance Sheet > short Term Investments
145193000
Quarters > 3 > balance Sheet > receivables
146000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
188631000
Quarters > 3 > balance Sheet > property Plant Equipment
20425000
Quarters > 3 > balance Sheet > total Assets
209581000
Quarters > 3 > balance Sheet > payables
1121000
Quarters > 3 > balance Sheet > short Term Debt
3740000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
22940000
Quarters > 3 > balance Sheet > equity
186641000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-16095000
Quarters > 3 > cash Flow > depreciation
614000
Quarters > 3 > cash Flow > change In Working Capital
-311000
Quarters > 3 > cash Flow > cash From Operations
-14650000
Quarters > 3 > cash Flow > capital Expenditures
64000
Quarters > 3 > cash Flow > cash From Investing
-966000
Quarters > 3 > cash Flow > cash From Financing
-30000
Quarters > 3 > cash Flow > net Change In Cash
-15646000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.3782356438024212
Quarters > 3 > ratios > PB
0.6024174441039215
Quarters > 3 > ratios > ROE
-4.93728601968485
Quarters > 3 > ratios > ROA
-4.3968680367018
Quarters > 3 > ratios > FCF
-14714000
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
41
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
251000
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
251000
Annuals > 0 > income Statement > operating Expenses
67533000
Annuals > 0 > income Statement > operating Income
-67282000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-58493000
Annuals > 0 > income Statement > net Income
-58493000
Annuals > 0 > income Statement > eps
-2.4008830724834533
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
24363119
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-64851000
Annuals > 0 > income Statement > operating Margin
-26805.57768924303
Annuals > 0 > income Statement > total Other Income Expense Net
8789000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
40235000
Annuals > 0 > balance Sheet > short Term Investments
145193000
Annuals > 0 > balance Sheet > receivables
146000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
188631000
Annuals > 0 > balance Sheet > property Plant Equipment
20425000
Annuals > 0 > balance Sheet > total Assets
209581000
Annuals > 0 > balance Sheet > payables
1121000
Annuals > 0 > balance Sheet > short Term Debt
3740000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
22940000
Annuals > 0 > balance Sheet > equity
186641000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-65373000
Annuals > 0 > cash Flow > depreciation
2431000
Annuals > 0 > cash Flow > change In Working Capital
-325000
Annuals > 0 > cash Flow > cash From Operations
-55032000
Annuals > 0 > cash Flow > capital Expenditures
642000
Annuals > 0 > cash Flow > cash From Investing
-120463000
Annuals > 0 > cash Flow > cash From Financing
162226000
Annuals > 0 > cash Flow > net Change In Cash
-13269000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-2.4008830724834533
Annuals > 0 > ratios > PB
0.6024174441039215
Annuals > 0 > ratios > ROE
-31.33984494296537
Annuals > 0 > ratios > ROA
-27.90949561267481
Annuals > 0 > ratios > FCF
-55674000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-221.80876494023903
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
33492000
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
33492000
Annuals > 1 > income Statement > operating Expenses
64163000
Annuals > 1 > income Statement > operating Income
-30671000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-27624000
Annuals > 1 > income Statement > net Income
-27696000
Annuals > 1 > income Statement > eps
-1.1896109543513855
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
23281561
Annuals > 1 > income Statement > income Tax Expense
72000
Annuals > 1 > income Statement > EBITDA
-28405000
Annuals > 1 > income Statement > operating Margin
-91.5770930371432
Annuals > 1 > income Statement > total Other Income Expense Net
3047000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
53504000
Annuals > 1 > balance Sheet > short Term Investments
23467000
Annuals > 1 > balance Sheet > receivables
1758000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
79821000
Annuals > 1 > balance Sheet > property Plant Equipment
24643000
Annuals > 1 > balance Sheet > total Assets
105114000
Annuals > 1 > balance Sheet > payables
614000
Annuals > 1 > balance Sheet > short Term Debt
3596000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
267129000
Annuals > 1 > balance Sheet > equity
-162015000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-28720000
Annuals > 1 > cash Flow > depreciation
2266000
Annuals > 1 > cash Flow > change In Working Capital
-28280000
Annuals > 1 > cash Flow > cash From Operations
-47430000
Annuals > 1 > cash Flow > capital Expenditures
3258000
Annuals > 1 > cash Flow > cash From Investing
-25975000
Annuals > 1 > cash Flow > cash From Financing
24391000
Annuals > 1 > cash Flow > net Change In Cash
-49014000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-1.1896109543513855
Annuals > 1 > ratios > PB
-0.6631756566675926
Annuals > 1 > ratios > ROE
17.094713452458105
Annuals > 1 > ratios > ROA
-26.34853587533535
Annuals > 1 > ratios > FCF
-50688000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-1.5134360444285202
Annuals > 1 > health Score
28
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
4931000
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
4931000
Annuals > 2 > income Statement > operating Expenses
64760000
Annuals > 2 > income Statement > operating Income
-59829000
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-58335000
Annuals > 2 > income Statement > net Income
-58388000
Annuals > 2 > income Statement > eps
-3.3206559438621013
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
17583273
Annuals > 2 > income Statement > income Tax Expense
53000
Annuals > 2 > income Statement > EBITDA
-58671000
Annuals > 2 > income Statement > operating Margin
-1213.3238693976882
Annuals > 2 > income Statement > total Other Income Expense Net
1494000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
102531000
Annuals > 2 > balance Sheet > short Term Investments
0
Annuals > 2 > balance Sheet > receivables
525000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
104675000
Annuals > 2 > balance Sheet > property Plant Equipment
27612000
Annuals > 2 > balance Sheet > total Assets
133054000
Annuals > 2 > balance Sheet > payables
1096000
Annuals > 2 > balance Sheet > short Term Debt
3486000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
273750000
Annuals > 2 > balance Sheet > equity
-140696000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-58788000
Annuals > 2 > cash Flow > depreciation
1158000
Annuals > 2 > cash Flow > change In Working Capital
-3866000
Annuals > 2 > cash Flow > cash From Operations
-50829000
Annuals > 2 > cash Flow > capital Expenditures
6299000
Annuals > 2 > cash Flow > cash From Investing
-6299000
Annuals > 2 > cash Flow > cash From Financing
-1264000
Annuals > 2 > cash Flow > net Change In Cash
-58392000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-3.3206559438621013
Annuals > 2 > ratios > PB
-0.5767527498649571
Annuals > 2 > ratios > ROE
41.49940296810144
Annuals > 2 > ratios > ROA
-43.882934748297686
Annuals > 2 > ratios > FCF
-57128000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-11.585479618738592
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
2002000
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
2002000
Annuals > 3 > income Statement > operating Expenses
55274000
Annuals > 3 > income Statement > operating Income
-53272000
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-71825000
Annuals > 3 > income Statement > net Income
-71825000
Annuals > 3 > income Statement > eps
-4.0848481394789244
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
17583273
Annuals > 3 > income Statement > income Tax Expense
-18553000
Annuals > 3 > income Statement > EBITDA
-71577000
Annuals > 3 > income Statement > operating Margin
-2660.9390609390607
Annuals > 3 > income Statement > total Other Income Expense Net
-18553000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
160923000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
468000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
162287000
Annuals > 3 > balance Sheet > property Plant Equipment
4078000
Annuals > 3 > balance Sheet > total Assets
169926000
Annuals > 3 > balance Sheet > payables
1444000
Annuals > 3 > balance Sheet > short Term Debt
433000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
258784000
Annuals > 3 > balance Sheet > equity
-88858000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-71825000
Annuals > 3 > cash Flow > depreciation
248000
Annuals > 3 > cash Flow > change In Working Capital
33413000
Annuals > 3 > cash Flow > cash From Operations
-15304000
Annuals > 3 > cash Flow > capital Expenditures
1724000
Annuals > 3 > cash Flow > cash From Investing
-1724000
Annuals > 3 > cash Flow > cash From Financing
152754000
Annuals > 3 > cash Flow > net Change In Cash
135726000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-4.0848481394789244
Annuals > 3 > ratios > PB
-0.913218898636026
Annuals > 3 > ratios > ROE
80.83121384681176
Annuals > 3 > ratios > ROA
-42.26839918552782
Annuals > 3 > ratios > FCF
-17028000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-8.505494505494505
Annuals > 3 > health Score
30
Valuation > metrics > PE
-0.8793499084745754
Valuation > metrics > PB
0.8743201565059134
Valuation > final Score
70
Valuation > verdict
12.6% Undervalued
Profitability > metrics > ROE
-16.65944419503687
Profitability > metrics > ROA
-16.620857910503073
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.15196867572562894
Risk > metrics > Interest Coverage
-34.58761329305136
Risk > final Score
-78
Risk > verdict
High
Liquidity > metrics > Current Ratio
32.21990049751244
Liquidity > metrics > Quick Ratio
32.21990049751244
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-40
Prev Risks > 1
-12
Prev Risks > 2
51
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:24:59.728Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-18
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.88
Earnings History > 0 > eps Estimate
-0.8
Earnings History > 0 > eps Difference
-0.08
Earnings History > 0 > surprise Percent
-10
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
AfterMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.87
Earnings History > 1 > eps Estimate
-0.77
Earnings History > 1 > eps Difference
-0.1
Earnings History > 1 > surprise Percent
-12.987
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-08
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.83
Earnings History > 2 > eps Estimate
-0.62
Earnings History > 2 > eps Difference
-0.21
Earnings History > 2 > surprise Percent
-33.871
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-24
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.66
Earnings History > 3 > eps Estimate
-0.58
Earnings History > 3 > eps Difference
-0.08
Earnings History > 3 > surprise Percent
-13.7931
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-12
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.87
Earnings History > 4 > eps Estimate
-0.63
Earnings History > 4 > eps Difference
-0.24
Earnings History > 4 > surprise Percent
-38.0952
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-29
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-22
Earnings History > 5 > eps Estimate
-4.4
Earnings History > 5 > eps Difference
-17.6
Earnings History > 5 > surprise Percent
-400
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-29
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-1.49
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-1.49
Earnings History > 6 > surprise Percent
-
Artiva Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing natural killer (NK) cell-based therapies for patients suffering from autoimmune diseases and cancers. The company's lead product candidate includes AlloNK, an off-the-shelf NK cell therapy for patients with autoimmune diseases and cancers, such as rheumatoid arthritis, systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, pemphigus vulgaris, the anti-neutrophil cytoplasmic antibody -associated vasculitis subtypes granulomatosis with polyangiitis/microscopic polyangiitis, and B-cell-non-Hodgkin lymphoma. It also develops AB-201, an allogeneic anti- human epidermal growth factor receptor 2 targeting chimeric antigen receptor (CAR)-NK cell product candidate for the treatment of various solid tumors, such as breast, gastric and esophageal, and bladder cancers; and AB-205, an allogeneic anti-CD5 CAR-NK cell product candidate for the treatment of hematological malignancies. Artiva Biotherapeutics, Inc. was incorporated in 2019 and is headquartered in San Diego, California.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AIs ARTV stock good for income investors - Global Markets & Verified Entry Point Detection bollywoodhelpline.com
Read more →Artiva Biotherapeutics Stock: Upcoming Data Presentations In Focus (NASDAQ:ARTV) - Seeking Alpha
1/16/2026
Artiva Biotherapeutics Stock: Upcoming Data Presentations In Focus (NASDAQ:ARTV) Seeking Alpha
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$17
Analyst Picks
Strong Buy
4
Buy
2
Hold
0
Sell
0
Strong Sell
0
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Artiva Biotherapeutics, Inc. Common Stock
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.88
EPS Estimate
-0.8
EPS Difference
-0.08
Surprise Percent
-10%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.